COMMUNIQUÉS West-GlobeNewswire

83% of People with Alcohol Problems Are Never Encouraged to Seek Treatment

18/04/2018 - 13:48

VANCOUVER, B.C., April 18, 2018 (GLOBE NEWSWIRE) -- With April being Alcohol Awareness Month, studies show 83% of Canadians who drink excessively received no advice or encouragement from family and friends to cut down [...]

AzurRx BioPharma Announces Positive Preclinical Data with AZX1103

18/04/2018 - 13:45

Company is developing AZX1103 for the prevention of nosocomial infections induced by administration of several classes of antibiotics AZX1103 shown to be safe and biologically active in a well-established pre-clinical [...]

Precipio in Strategic Partnership Discussions for Proprietary Cytogenetics Media IV-Cell

18/04/2018 - 13:38

NEW HAVEN, Conn., April 18, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), announced today it is in active licensing discussions with several potential partners regarding IV-Cell [...]

Conatus Pharmaceuticals’ IDN-7314 Pan-caspase Inhibitor Reduces Hepatic Tissue Factor-Driven Coagulation In Vitro and In Vivo

18/04/2018 - 13:30

SAN DIEGO, April 18, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq: CNAT ), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today [...]

Radient Technologies Inc. Finalizes Real Estate Transactions for Expansion and Provides Corporate Update

18/04/2018 - 13:30

EDMONTON, Alberta, April 18, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture:RTI) is pleased to announce the following update on its operations and 2018 growth initiatives. [...]

Actinium Pharmaceuticals Strengthens Targeted Myeloablation Focused Clinical Development Team with New Hires Including Experienced Bone Marrow Transplant Physician and Drug Developer Vijay Reddy, M.D., Ph.D. as Vice President, Clinical Development

18/04/2018 - 13:30

- Dr. Vijay Reddy joins Actinium with over 20 years of bone marrow transplant clinical experience including extensive product development experience at Pharmacyclics, an AbbVie Company, Medimmune and Johnson & [...]

Solid Biosciences Provides Update On SGT-001 Clinical Development Program For Duchenne Muscular Dystrophy

18/04/2018 - 13:30

- Full Clinical Hold Letter from the FDA Received; Company to Respond in the Coming Weeks - - Manufacturing-related Partial Clinical Hold on the High Dose of SGT-001 Resolved - CAMBRIDGE, Mass., April 18, 2018 (GLOBE [...]

Calithera Biosciences Announces FDA Fast Track Designation Granted to CB-839 in Combination with Cabozantinib for Treatment of Patients with Advanced Renal Cell Carcinoma

18/04/2018 - 13:01

Randomized CANTATA trial open for enrollment SOUTH SAN FRANCISCO, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA ), a clinical stage biotechnology company focused on the development [...]

AxoGen, Inc. to Report First Quarter 2018 Financial Results and Host Conference Call on April 30, 2018

18/04/2018 - 13:00

ALACHUA, Fla., April 18, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that it will report first [...]

EyePoint Pharmaceuticals’ YUTIQ™ for Posterior Segment Uveitis to be Presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

18/04/2018 - 13:00

WATERTOWN, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ: EYPT ) (ASX:PVA), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, [...]

AGTC Doses First Patient in Phase 1/2 Clinical Study of Gene Therapy for the Treatment of X-Linked Retinitis Pigmentosa

18/04/2018 - 13:00

GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ: AGTC ), a biotechnology company conducting human clinical trials of adeno-associated virus ( [...]

Trillium Therapeutics Reports TTI-622 Preclinical Data at the 2018 AACR Annual Meeting

18/04/2018 - 13:00

TORONTO, April 18, 2018 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Nasdaq: TRIL ) (TSX: TRIL ), a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced [...]

Capital Senior Living Corporation Announces Release Date for First Quarter 2018 Financial Results

18/04/2018 - 12:00

DALLAS, April 18, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (NYSE: CSU ) will host a conference call with senior management to discuss the Company’s first quarter 2018 financial results. The call will [...]

Mesoblast Clinical Program Update for MPC-150-IM in Patients With Chronic Heart Failure

18/04/2018 - 12:00

NEW YORK and MELBOURNE, Australia, April 18, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO ) (ASX:MSB) today provided an update on the Phase 3 and Phase 2b clinical trials of the Company's proprietary [...]

HealthLynked Corp. Announces Software Update Allowing Users Complete Control of Medical Record Sharing and Access

18/04/2018 - 11:00

NAPLES, Fla., April 18, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK) today announced release of its access control panel feature. A key service to members of the HealthLynked Network is the ability to share [...]

Dr. Michael K. Pugsley Joins Veritas Pharma’s Advisory Board

18/04/2018 - 09:50

VANCOUVER, British Columbia, April 18, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to announce that Dr. Michael K. Pugsley PhD, FBPhS, [...]

Basilea reports start of clinical phase 3 study in Japan by Asahi Kasei Pharma with antifungal isavuconazole

18/04/2018 - 07:16

Basel, Switzerland, April 18, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its license partner Asahi Kasei Pharma Corporation ("Asahi Kasei Pharma") has started enrollment in a clinical phase 3 [...]

Curetis: Novel Products and Study Data to be Presented at ECCMID 2018

18/04/2018 - 07:02

Curetis: Novel Products and Study Data to be Presented at ECCMID 2018 Introduction of Unyvero UTI Application Cartridge Update on A30 RQ Analyzer to be provided MGI/Curetis NGS Solution for Molecular Microbiology to be [...]

GUERBET : 1st quarter 2018 revenue

18/04/2018 - 07:01

€196.5 million at constant exchange rates: -3.2% Villepinte, April 18, 2018 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is reporting revenue of €183.2 million [...]